Condition: Cholecystectomy · Sponsor: Assaf-Harofeh Medical Center
Analgesia is one of the pillars of anesthesia. One of the common opiates for pain relief, with a short half-life, is Remifentanil. However, following Remifentanil treatment an increased sensitivity to pain \[hyperalgesia\] appears. The aim of the study is to compare the effects between complementary treatments, like Ketalar and Dexmedetomidine, in preventing increased sensitivity to pain after Remifentanil treatment
This description comes directly from the study's public registry record.
Sara Bar Yehuda, PhD · 972528981004 · sarabar1@shamir.gov.il
Zoya Haitov Ben Zikri, MD · 972537346186 · ZoyaC@shamir.gov.il
Always discuss trial participation with your own doctor first.
| Shamir (Asaf Harofe) Medical Center | Be’er Ya‘aqov, Israel | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06473896